Profit Margin (Quarterly) Chart

View Profit Margin (Quarterly) for IRMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Profit Margin (Quarterly) Chart
Start Trial

Historical Profit Margin (Quarterly) Data

View and export this data back to 2013. Start Trial.
Date Value
March 31, 2026 26.47%
December 31, 2025 28.39%
September 30, 2025 26.30%
June 30, 2025 28.29%
March 31, 2025 24.02%
December 31, 2024 26.54%
September 30, 2024 27.55%
June 30, 2024 27.34%
March 31, 2024 23.51%
December 31, 2023 26.01%
September 30, 2023 30.70%
June 30, 2023 25.91%
March 31, 2023 22.01%
December 31, 2022 24.71%
September 30, 2022 25.56%
June 30, 2022 25.48%
March 31, 2022 20.20%
December 31, 2021 32.79%
September 30, 2021 23.62%
June 30, 2021 14.98%
March 31, 2021 15.03%
December 31, 2020 7.46%
September 30, 2020 13.96%
June 30, 2020 -31.09%
March 31, 2020 20.39%
Date Value
December 31, 2019 29.77%
September 30, 2019 24.64%
June 30, 2019 22.64%
March 31, 2019 21.87%
December 31, 2018 20.47%
September 30, 2018 31.52%
June 30, 2018 18.37%
March 31, 2018 11.83%
December 31, 2017 2.74%
September 30, 2017 3.38%
June 30, 2017 6.46%
March 31, 2017 -4.52%
December 31, 2016 19.04%
September 30, 2016 20.34%
June 30, 2016 22.61%
March 31, 2016 25.46%
December 31, 2015 27.33%
September 30, 2015 22.79%
June 30, 2015 23.27%
March 31, 2015 21.28%
December 31, 2014 7.56%
September 30, 2014 6.23%
June 30, 2014 21.67%
March 31, 2014 14.71%
March 31, 2013 24.50%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Accuray, Inc. -11.26%
IDEXX Laboratories, Inc. 24.41%
Masimo Corp. 13.95%
Neogen Corp. -8.05%
QuidelOrtho Corp. -14.81%